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Chuanxin Wu1, Hang Sun2*, Hongliang Wang1, Junmeng Chi1, Qi Liu2, Hui Guo2 and Jianping Gong1Abstract
Objectives: To validate the role of high mobility group box-1(HMGB1) in diagnosis of acute appendicitis (AA) with
different pathological severity.
Methods: According to the pathologically diagnosis, 150 patients underwent appendectomies between Jan. 2007
and Dec, 2010 were divided into acute simple, acute suppurative and acute gangrenous appendicitis as group 1,
2 and 3, respectively. Each patient group contains 50 sex and age matched cases to make comparison with 50
healthy volunteers. The mRNA and protein expression levels of serum HMGB1 were determined by real-time
quantitative PCR and enzyme linked immunosorbent assay (ELISA). Serum High-sensitivity C-reactive protein
(hs-CRP) levels were determined by rate nephelometric immunoassay.
Results: In comparison with health volunteers, relative HMGB1 mRNA levels in group 1, 2 and 3 were significantly
increased 3.05 ± 0.51,8.33 ± 0.75 and 13.74 ± 1.09 folds, reflecting a tendency of augmented severity. In
accordance, serum protein levels of HMGB1 were 10.97 ± 1.64, 14.42 ± 1.56 and 18.08 ± 2.41 ng/ml in 3 patient
groups, which are significantly higher than that of healthy volunteers’ 5.47 ± 0.73 ng/ml. hs-CRP levels were
12.85 ± 3.41, 21.04 ± 1.98 and 31.07 ± 5.46 ng/ml in 3 patients groups compared with 2.06 ± 0.77 ng/ml in
controls. The concentrations of HMGB1 and hs-CRP were both positively correlated with disease severity.
Conclusion: Serum HMGB1 constitutes as a valuable marker in diagnosis of AA. Positively correlated with hs-CRP
level, mRNA and protein expression of HMGB1 to a certain extent reflected the severity of AA.
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Acute appendicitis is the most common acute abdominal
disease in general surgeries of patients with typical clin-
ical symptoms. The stages of AA can be divided into
simple, suppurative, gangrenous, perforated, recurrent,
and chronic etc. according to the severity of the diseases.
Although AA is not a life-threatening disease, mortality
is still reported as high as 1%. Diagnosis of AA is often a
clinical challenge because it can mimic several abdom-
inal pain conditions. So far no single symptom or diag-
nostic test can accurately confirm the diagnosis of AA in* Correspondence: sunhangwu@yahoo.com
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reproduction in any medium, provided the orall cases. The emergencies are sometimes misdiagnosed
or missed. Although the surgery appendectomy itself is a
relatively safe surgical procedure, rates of negative ap-
pendectomy and perforated appendicitis remain fairly
high, around 10–30 percent, with a higher rate of ~40%
in high risk populations such as women of reproductive
age. For a long time, the preoperative diagnosis of AA is
largely relied on the clinical assessment, previous experi-
ence, total white blood cell (WBC) counts, neutrophil
percentage or a combination of several examinations.
These traditional methods are rather nonspecific. Re-
cently ultrasonography and computed tomography were
applied in diagnosis of AA. However, it is still controver-
sial if these imaging aided applications have actually
resulted in significantly reduced cases of negative ap-
pendectomy and perforated appendicitis [1,2]. Therefore,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ically highly desirable, which can to a certain extent re-
flect the severity of the AA condition.
HMGB1 is recently identified inflammatory factor
which plays a crucial role in the late stage of severe sep-
sis. It is highly expressed in severe sepsis, acute pancrea-
titis, hemorrhagic shock, severe trauma and acute lung
injury. And its expression is closely correlated with the
severity of these symptoms [3–5]. Recent study has
demonstrated that HMGB1 level was increased in serum
sample of AA patients. Although preliminary, it was
indicated that HMGB1 is a potential candidate to aid in
AA diagnostic [6].
In this study, we have evaluated the mRNA and protein
expression level of HMGB1 in AA patients. In addition,
HMGB1 was assessed to be a diagnostic marker for AA
patients with differential pathological severity of the dis-
ease, aiming to provide a valuable marker to improve the
preoperative diagnosis of AA for clinical use.
Material and methods
Study population
According to the pathologically diagnosis, 150 patients
underwent appendectomies between Jan. 2007 and Dec
2010 were divided into acute simple, acute suppurative
and acute gangrenous appendicitis as group 1, 2 and 3,
respectively. All experimental protocols were approved
by the local research ethics committee of the Second
Affiliated Hospital of Chongqing Medical University and
complied with the China government guidelines. There
are randomized chosen 25 males and 25 females in each
AA group. The average age for acute simple, acute sup-
purative and acute gangrenous appendicitis groups are
37.63 ± 14.68, 34.72 ± 15.45 and 36.63 ± 15.98 respect-
ively. 50 healthy volunteers (25 males and 25 females,
average age 38.77 ± 13.29) without any abdominal syn-
dromes were used as a control group. Blood samples of
the patients were withdrawn when admitted to the
hospital. White blood cells were counted and the
blood samples were stored for future use. No signifi-
cant differences were observed in age, family history
and other medical conditions between groups.
Serum HMGB1
Serum HMGB1 concentrations were measured by ELISA
with human HMGB1 detection ELISA kit (SUNBIO
(Cat# HE017), Beijing, China) according to the manufac-
turer’s instruction.
Relative mRNA expression level
Peripheral blood total RNA was isolated with total RNA
isolation kit purchased from Bioteke, Beijing, China,
according to manufacturers’ instruction. RNA was re-
verse transcribed using PrimeScriptW RT reagent Kit(Perfect Real Time) from TaKaRa biotech, Dalian, China.
SYBRW Premix Ex Taq™ (Perfect Real Time) from
TaKaRa was used for quantitative real-time PCR. The
primers for human HMGB1 were designed with Pri-
mier4.1 software, GADPH was used as a reference gene.
Both primers were synthesized by TaKara. Primers used
for human HMGB1 are, forward: 5’-GCG GAC AAG
GCC CGT TA-3’; reverse: 5’-AGA GGA AGA AGG
CCG AAG GAA-3’; Amplicon size 119 bp. Human
GADPH primers are Forward: 5’- TGC CAA ATA TGA
TGA CAT CAA GAA-3’; Reverse: 5’- GGA GTG GGT
GTC GCT GTT G-3’; Amplicon size 121 bp. Relative
gene expression was calculated to that of GAPDH on
the basis of ΔCt value. Data with 2-44CT > 2, were con-
sidered to be statistically significant.
Hs-CRP concentration
Serum Hs-CRP concentrations were determined locally
in clinical laboratory of the hospital with rate nephelo-
metric immunoassay.
Statistical analysis
Values were expressed as the standard deviations of the
mean. Data were analyzed with SPSS 13.0 software. Group
means did not exhibited as normal distribution and were
examined using Kruskal-Wallis test. The P values of less
than 0.05 were considered to be statistically significant.
Results
HMGB1 protein concentration in AA patients
The average HMGB1 protein level in acute simple
(group 1), acute suppurative (group 2) and acute gan-
grenous appendicitis (group 3) are 10.97 ± 1.64 ng/ml,
14.42 ± 1.56 ng/ml and 18.08 ± 2.41 ng/ml,which is sig-
nificantly higher than that of health volunteer group at
5.47 ± 0.73 ng/ml (P <0.01). The HMGB1 concentration
in acute simple appendicitis group is almost doubled
compared with healthy controls. And acute gangrenous
appendicitis is about 4 folds higher in HMGB1 secretion.
Importantly, HMGB1 concentration in group 2 is signifi-
cantly higher than that of group 1, and group 3 is much
higher than group 2 (P < 0.01, Figure 1). It is indicated
that with the exacerbated inflammation and worsen of
the disease, HMGB1 protein level in the peripheral
blood is significantly increased and is correlated with the
severity of AA.
HMGB1 mRNA expression in AA patients
In comparison with that of health volunteers, the
HMGB1 mRNA expression level of patients in acute
simple (group 1), acute suppurative (group 2) and acute
gangrenous appendicitis (group 3) are 3.05 ± 0.51,8.33 ±
0.75 and 13.74 ± 1.09 (Figure 2). The 2-44CT value of
HMGB1 in all three AA groups are higher than 2,
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Figure 1 Serum HMGB1 concentration in patient groups of
acute simple (group 1), acute suppurative (group 2) and acute
gangrenous appendicitis (group 3) in comparison with healthy
volunteers (group 0). *, P<0.01 compared with healthy volunteers;
▲ P<0.01 compared with acute simple (group 1) patients; # P<0.01
compared with acute suppurative (group 2) patients.
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HMGB1 expression is significantly increased. In
addition, HMGB1 expression in group 2 is significantly
higher than that of group1 (P < 0.01), and group 3 is sig-
nificantly higher than group 2 (P < 0.01), indicating that
the increased HMGB1 level is positively correlated with
the severity of the AA conditions.
Serum Hs-CRP concentrations in AA patients
CRP levels in acute simple (group 1), acute suppurative
(group 2) and acute gangrenous appendicitis (group 3)
are 12.85 ± 3.41 ng/ml, 21.04 ± 1.98 and 31.07 ±
5.46 ng/ml, which are all significantly higher than that of
healthy volunteer group at 2.06 ± 0.77 ng/ml(P <0.01).
Hs-CRP concentration in group 2 is significantly higher
than that of group 1 and group 3 is higher than group 2*
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Figure 2 Serum HMGB1 relative mRNA expression in patient
groups of acute simple (group 1), acute suppurative (group 2)
and acute gangrenous appendicitis (group 3) in comparison
with healthy volunteers (group 0). *, P<0.01 compared with
healthy volunteers; ▲ P<0.01 compared with acute simple (group 1)
patients; # P<0.01 compared with acute suppurative (group 2)
patients.(P < 0.01, Figure 3). Hs-CRP level also exhibits a positive
correlation with the severity of AA.
Peripheral blood white blood cell counts in AA patients
White blood cells counts of acute suppurative (group
2) and acute gangrenous appendicitis (group 3) are
12.90 ± 3.69 × 109 and 13.53 ± 4.31 × 109, respect-
ively, which are both significantly higher than that of acute
simple appendicitis patients (group 1) at 8.73 ± 3.49 × 109
and healthy volunteer group at 7.45 ± 2.98 × 109(P <0.01).
Importantly, we did not observe a significant increase in
simple appendicitis patients group and healthy volunteer
group (P >0.05), demonstrating that WBC is not a bona
fide diagnostic marker for AA, especially at the early stage
of AA progression. We also did not observe a significant
difference in WBC counts between group 1 and 2, indi-
cating that WBC counts are not very sensitive to reflect
the severity of AA (Figure 4).
Correlation analysis between serum HMGB1 and Hs-CRP
in AA patients
Statistical analysis demonstrated that in AA patients,
serum HMGB1 and Hs-CRP are positively correlated.
Both factors are increased with the development of
AA and in accordance with the severity of the disease
(r = 0.901, P <0.01, Figure 5).
Discussion
HMGB1 is a very abundant chromatin-binding protein
residing in the eukaryotic cell nucleus. Originally identi-
fied as a chromosomal protein regulating gene transcrip-
tion, HMGB1 is one of the most evolutionary
conservative proteins in the eukaryotic organism. It func-
tions to stabilize nucleosome formation, to promote the
binding of transcription factors to target DNA sequence,
and to play an important role in DNA recombination,*
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Figure 3 Serum Hs-CRP concentration in patient groups of
acute simple (group 1), acute suppurative (group 2) and acute
gangrenous appendicitis (group 3) in comparison with healthy
volunteers (group 0). *, P<0.01 compared with healthy volunteers;
▲ P<0.01 compared with acute simple (group 1) patients; # P<0.01
compared with acute suppurative (group 2) patients.
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Figure 4 White blood cell counts of acute simple (group 1),
acute suppurative (group 2) and acute gangrenous
appendicitis (group 3) in comparison with healthy volunteers
(group 0). *, P<0.01 compared with healthy volunteers; ▲ P<0.01
compared with acute simple (group 1) patients.
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side nucleus, HMGB1 is a potent DNA binding factors
but outside of the cells it acts as an inflammatory medi-
ator. HMGB1 is shown to be actively secreted by acti-
vated monocytes or macrophages. In addition, it can also
be passively released from necrotic or damaged cells to
act as a potent cytokine to trigger inflammation. The
secreted or leaked HMGB1 in the outside of the cellular
membrane, as an important inflammatory mediator in
late stage sepsis, is highly expressed in various inflamma-
tory diseases and in severe sepsis. In addition, HMGB1
was considered to play a crucial role in endotoxin
induced death effects in patients [8,9].
AA is characterized by acute suppurative infection.
When left untreated, AA can cause systemic inflamma-
tory symptoms and has the potential to develop into
severe complications such as perforation or sepsis. Al-
though AA is not a disease with high mortality, diag-
nosis of AA is often misdiagnosed or missed.Serum HMGB1 conc. (ng/ml)
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Figure 5 Correlation analysis between serum HMGB1 and
Hs-CRP in AA patients. r=0.901, P <0.01.Unnecessary appendectomy can cause surgical risks for
patients and waste of the money for the societies. Cur-
rently available preoperative diagnosis of AA is either
auxiliary or nonconfirmative. Identification of novel
diagnostic markers of AA is clinically highly desired.
Unfortunately not much attention had been paid to
connect HMGB1 and AA preoperative diagnosis.
In this study, we have investigated the diagnostic po-
tential of HMGB1, both at mRNA and protein levels in
AA patients. The average HMGB1 mRNA and protein
levels in acute simple, acute suppurative and acute gan-
grenous appendicitis group are significantly higher than
that of health volunteer group. Importantly, HMGB1
concentration in acute suppurative group is significantly
higher than that of acute simple appendicitis. Similarly,
acute gangrenous appendicitis group is much higher
than the other 2 less severe AA. It is indicated that with
the exacerbation of AA, HMGB1 mRNA and protein
levels are positively correlated with the severity of the
disease.
We have also examined the PBMC WBC counts in
patients with various pathological severities in compari-
son with health volunteers. It is showed that although
the WBC counts in patients groups of acute suppurative
and acute gangrenous appendicitis are significantly
higher than that in acute simple of healthy volunteers,
there is no significant difference between these 2 patient
groups. Importantly, there is barely any significant differ-
ence in WBC counts between acute simple appendicitis
patients and healthy volunteers, indicating that using
this index can lead to missed treatment and rather not
sensitive. Clearly WBC can not reflect the severity of the
AA condition. In comparison, the mRNA and protein
level of HMGB1 in acute simple patients are significantly
higher than healthy volunteers. It suggests that detection
of serum HMGB1 level is instrumental and confirmative
assay to diagnose AA. It will be especially valuable to
diagnose patients with AA syndrome but with normal
WBC counts.
After infection, both bacteria produced endotoxins
and various cytokines released by activated monocytes/
macrophages such as TNFα, IL1β, IFNγ etc. can pro-
mote HMGB1 translocation from nucleus to cytoplasmic
organelles. Eventually HBGB1 is secreted or released to
the extracellular area and further promote the transcrip-
tional synthesis of HMGB1 itself to provide additional
backup [10–12]. In addition, released HMGB1 itself acts
as a potent cytokine which can stimulate multiple proin-
flammatory cytokine release and can worsen the inflam-
mation. From this point of view, HMGB1 level to a
certain extent should be able to reflect the severity of
sepsis and infectious disease such as AA, useful to be a
diagnostic marker. It has been shown that inhibition the
expression and release of HMGB1 can attenuate the
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sepsis [9,13]. In acute AA, bacteria invade and infect the
wall of the appendix, causing releasing of bacterial endo-
toxin and proinflammatory cytokines. These factors can
potently activate monocytes/macrophages to release
HMGB1, followed by an elevated PBMC HMGB1 ex-
pression and secretion. The released HMGB1 can not
only worsen the local inflammation but also affect the
distal organ damage. Therefore, HMGB1 might play an
important role in the pathological progress of AA, and
can be clinically treated as a therapeutic target. Control-
ling its expression and release might improve the AA
therapy efficacy, manage systemic inflammation and re-
duce the organ injury from severe sepsis.
Several recently studies have tried to identify sensitive
diagnostic markers reflecting the severity of AA, such as
bilirubin and procalcitonin levels. In a prospective study,
Procalcitonin, an established marker of inflection and
sepsis, only increased with rare case of AA [14]. It is re-
markably low sensitivity prevented its clinical use as
diagnostic marker of AA. A recent study by Wu et al.
confirmed that procalcitonin test might not be useful for
AA patients [15]. Another promising marker is bilirubin.
Hyperbilirubinemia was assessed as a predictive marker
for appendiceal perforation in a large group of 538
patients, showing very high specificity and reasonably
good sensitivity [16]. However, another study has demon-
strated that bilirubin is inferior to CRP for anticipation of
perforation of AA [17]. Therefore, novel markers that
can predict the severity of AA are still highly desirable.
Hs-CRP concentration increases in various injury and in-
flammatory diseases, such as cardiovascular diseases. It is
deemed to be a risk factor for patients with heart disease.
Its serum concentration to a certain extent reflects the
severity of the inflammation; however, it is rather non-
specific as it cannot pinpoint the location of the inflam-
mation. In addition, it is also an indicator of system
inflammation. Therefore, combination detection with
other markers to diagnose AA is necessary, especially for
those patients who have cardiovascular diseases. In our
study, Hs-CRP levels in acute simple, acute suppurative
and acute gangrenous appendicitis patients are all signifi-
cantly higher than that of healthy volunteers. Hs-CRP
concentration in acute suppurative is significantly higher
than that of acute simple, and Hs-CRP of acute gangren-
ous appendicitis patients is remarkably higher than acute
suppurative group (P < 0.01, Figure 3). Hs-CRP level
exhibits a positive correlation with the severity of AA. As
serum HMGB1 and Hs-CRP are positively correlated
with the severity of AA, a combination use of both mar-
kers will be useful for the evaluation and conformation of
the severity of the diseases before operation.
In conclusion, as HMGB1 plays a crucial role in the
pathophysiological process of inflammatory diseasessuch as AA, serum HMGB1 level constitutes a novel
marker in the diagnosis of AA. It even holds promise to
help doctors to judge the severity of the acute syndrome
under different stage of AA with A combination detec-
tion of HMGB1 and Hs-CRP.
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